Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 23.29.
Forward PE Ratio (23.29) = Close Price ($236.63) / Consensus Forward EPS ($10.20)
FORWARD PE RATIO
23.29
SECTOR MEDIAN · HEALTHCARE
20.44
median of 67 covered companies
CURRENT VS SECTOR MEDIAN
+13.94%
vs the sector median at left
STERIS plc
Market Cap
$23.06B
Forward PE Ratio
23.29
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| STERIS plc (STE) | $23.06B | 23.29 |
| BioNTech SE (BNTX)vs › | $23.41B | N/A |
| Moderna, Inc. (MRNA)vs › | $23.66B | N/A |
| United Therapeutics Corporation (UTHR)vs › | $22.26B | 20.44 |
| Incyte Corporation (INCY)vs › | $24.84B | 28.83 |
| West Pharmaceutical Services, Inc. (WST)vs › | $25.06B | 39.59 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.25B | 21.30 |
| Labcorp Holdings Inc. (LH)vs › | $26.27B | 17.48 |
| Viatris Inc. (VTRS)vs › | $19.04B | 6.71 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.69B | 11.32 |
Trailing P/E
29.0
reported TTM EPS
Forward P/E
23.3
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.20 implies +24.7% EPS growth vs the reported trailing $8.18.
At today's $236.63 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-03-31 | $11.15 | $11.12 – $11.16 | 6 | 21.2x |
| 2028-03-31 | $12.14 | $12.10 – $12.17 | 5 | 19.5x |
| 2029-03-31 | $13.20 | $13.06 – $13.34 | 2 | 17.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
